Brief: Suven Pharmaceuticals Named Sudhir Kumar Singh As CEO
29/09/2023 16:32
Sept 29 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* NAMED VETUKURI VENKATA NAGA KALI VARA PRASADA RAJU AS MD
* NAMED SUDHIR KUMAR SINGH AS CEO
Source text for Eikon: ID:nBSE7tPdp9
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss